A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion

NCT01529957 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2012-02-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and tolerability of nemonoxacin in healthy Chinese volunteers.

Conditions

  • Healthy

Interventions

DRUG

Nemonoxacin Malate Sodium Chloride

Nemonoxacin Malate Sodium Chloride,intravenous injection,once daily

Sponsors & Collaborators

  • TaiGen Biotechnology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Yingyuan Zhang, PhD · Huashan Hospital, Fundan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01529957 on ClinicalTrials.gov